Aska Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aska Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Nippon Chemiphar Co., Ltd.
sales of 35.33 billion Japanese Yen [US$313.74 million]
of which 97%
was Pharmaceutical Business),
Eiken Chemical Co., Ltd.
(34.99 billion Japanese Yen [US$310.72 million]
of which 55%
was Immunoserology Test Agent), and
Fuso Pharmaceutical Industries Ltd
(45.90 billion Japanese Yen [US$407.59 million]
of which 100%
was Pharmaceutical Business).
Aska Pharmaceutical Company Limited reported sales of ¥48.94 billion (US$434.62 million)
March of 2018.
a very small
increase of 0.9%
versus 2017, when the company's sales were ¥48.53 billion.
This was the fourth straight year of sales growth at Aska Pharmaceutical Company Limited.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
8.4% in 2018, from
¥4.44 billion to ¥4.82 billion.